v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash Flows From Operating Activities    
Net Loss $ (16,983,981) $ (21,360,865)
Stock-based compensation:    
Shares issued for services 270,967 2,099,582
Amortization of stock options and restricted stock shares 2,002,980 1,871,473
Impairment of goodwill 18,872,850
Depreciation and amortization 71,396 93,139
Bad debt expense – related parties 338,582
Gain on settlement of liabilities (927,698)
Loss on extinguishment of convertible note payable 9,737
Deferred tax benefit (16,587)
Offering costs allocated to warrant liabilities 604,118
Change in fair value of derivative liabilities (14,167,560) 10,342,337
Change in fair value of accrued issuable equity 9,405
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 36,340 (443,531)
Accounts payable 428,632 (5,458,875)
Accounts payable – related parties (211,048)
Accrued expenses 127,449 (799,764)
Accrued expenses – related parties 140,097 (441,403)
Accrued issuable equity (52,500)
Total adjustments 7,783,151 7,016,967
Net Cash Used In Operating Activities (9,200,830) (14,343,898)
Cash Flows From Financing Activities    
Shares issued for cash, net of issuance costs 26,666,200
Proceeds from sale of common stock and common warrants 6,499,737
Proceeds from exercise of pre-funded warrants 155
Offering costs in connection with sale of common stock and warrants (529,982) (2,055,130)
Repayment of loans payable (1,491,986) (306,361)
Repayment of loans payable – related parties (431,838)
Repayment of convertible debt – related parties (10,000)
Net Cash Provided By Financing Activities 4,477,924 23,862,871
Effect of Exchange Rate Changes on Cash 87,037 60,283
Net (Decrease) Increase In Cash (4,635,869) 9,579,256
Cash - Beginning of Period 8,224,508 2,108,544
Cash - End of Period 3,588,639 11,687,800
Supplemental Disclosures of Cash Flow Information:    
Cash paid during the period for income taxes
Cash paid during the period for interest 13,423 31,428
Non-cash investing and financing activities:    
Warrants issued in connection with the private offering 7,294,836
Shares issued to settle accounts payable 1,973,250
Conversion of convertible debt and accrued interest into common stock 1,340,184
Common stock issued upon exchange of notes payable and accrued interest 1,283,496
Shares and warrants issued for Alpha settlement 1,156,177
Security deposit applied to accounts payable 7,078
Exchange of common stock equivalents for common stock $ 100

Source